İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

BURCU ÇALIŞKAN

PROFESÖR

GAZİ ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 51
  • Proje 0
  • Kitap 0
  • Bildiri 15
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 35 Q2 14 Q3 3 Q4 1
WoS (JCR) Q1 31 Q2 8 Q3 7 Q4 7
TR Index 3 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 6
Ort. yüzdelik 72.1%
Üst %1 payı 0.0%
Üst %10 payı 11.3%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 51 yayın

Scopus (SJR)
Q1 35 Q2 14 Q3 3 Q4 1
WoS (JCR)
Q1 31 Q2 8 Q3 7 Q4 7
TR Index
3 makale

Makale listesi

  1. 2025 2‐Phenylbenzothiazoles featuring heteroaryl sulfonamide end‐capping substructures as developable mPGES‐1 inhibitors Archiv der Pharmazie DOI 10.1002/ardp.202400756 YÖKSİS SJR Q2 JCR Q2 OpenAlex 59.5%
  2. 2025 Enhanced Efficiency of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AGU661 in Human Whole Blood by Encapsulation into PLGA-Based Nanoparticles Molecular Pharmaceutics DOI 10.1021/acs.molpharmaceut.5c00766 YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.2%
  3. 2025 Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.108644 YÖKSİS SJR Q1 JCR Q1 OpenAlex 74.5%
  4. 2025 Phenyl-benzyl-ureas with pyridazinone motif: Potent soluble epoxide hydrolase inhibitors with enhanced pharmacokinetics and efficacy in a paclitaxel-induced neuropathic pain model European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2025.117510 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 90.8%
  5. 2025 Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.108204 YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.4%
  6. 2025 Harnessing structure-activity relationships to repurpose the FLAP inhibitor BRP-7 into potent and selective sEH inhibitors BIOORGANIC CHEMISTRY DOI 10.1016/j.bioorg.2025.108997 YÖKSİS SJR Q1 JCR Q1 OpenAlex 67.9%
  7. 2024 Novel 1,3,4-oxadiazole derivatives as highly potent microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors Bioorganic Chemistry DOI 10.1016/j.bioorg.2024.107383 YÖKSİS SJR Q1 JCR Q1 OpenAlex 67.7%
  8. 2024 Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer Cancer Research DOI 10.1158/0008-5472.can-23-2812 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 96.9%
  9. 2024 Novel Benzimidazole Derivatives as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase 1 for the Potential Treatment of Inflammation, Pain, and Fever Journal of Medicinal Chemistry DOI 10.1021/acs.jmedchem.4c01883 YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.7%
  10. 2023 Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification CELL DEATH AND DIFFERENTIATION DOI 10.1038/s41418-023-01140-1 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 96.5%
  11. 2023 Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors ACS Omega DOI 10.1021/acsomega.2c06936 YÖKSİS SJR Q2 JCR Q2 OpenAlex 77.8%
  12. 2023 Design, Synthesis and Evaluation of Aryl‐Tailored Oxadiazole‐thiones as New Urease Inhibitors ChemistrySelect DOI 10.1002/slct.202204449 YÖKSİS SJR Q3 JCR Q3 OpenAlex 58.3%
  13. 2022 Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition ACS OMEGA DOI 10.1021/acsomega.2c04039 YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.1%
  14. 2022 Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity ACS Omega DOI 10.1021/acsomega.2c03405 YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.5%
  15. 2022 Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors CHEMMEDCHEM DOI 10.1002/cmdc.202200137 YÖKSİS SJR Q1 JCR Q2 OpenAlex 75.0%
  16. 2022 Development and molecular modeling studies of new thiadiazole piperazine urea derivatives as potential fatty acid amide hydrolase inhibitors ARCHIV DER PHARMAZIE DOI 10.1002/ardp.202200082 YÖKSİS SJR Q2 JCR Q1 OpenAlex 50.5%
  17. 2022 Novel potent benzimidazole-based microsomal prostaglandin E-2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C-4 synthase EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY DOI 10.1016/j.ejmech.2022.114167 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 90.9%
  18. 2021 Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2021.113489 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.2%
  19. 2021 Antimigratory effect of pyrazole derivatives through the induction of STAT1 phosphorylation in A549 cancer cells Journal of Pharmacy and Pharmacology DOI 10.1093/jpp/rgab022 YÖKSİS SJR Q2 JCR Q2 OpenAlex 57.5%
  20. 2021 Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy Bioorganic Chemistry DOI 10.1016/j.bioorg.2021.104861 YÖKSİS SJR Q2 JCR Q1 OpenAlex 79.2%

Akademisyenlere dön